Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Inflammatory bowel disease - Insights
Our robust menu of inflammatory bowel disease (IBD) testing can assist with the diagnosis and management of IBD and includes first-line fecal testing for calprotectin; serologic analysis of clinically relevant antibodies; and genetic...
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Find out why testing for anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies is recommended for differential diagnosis.
Head and neck pathology at Mayo Clinic Laboratories
Head and neck pathology consultations often relate to the classification of salivary, sinonasal, and oropharynx tumors.Check out Mayo Clinic Laboratories’ head and neck pathology section, which is integrated with the clinical practice at...
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.